Literature DB >> 29516370

Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis.

Isabella Tabaro1, Giuseppe Reimondo2, Giangiacomo Osella1, Caterina Aurizi3, Pasquale Caraci1, Luca Barbieri3, Daniela Francesca Giachino4, Fabio Sirchia5, Massimo Terzolo1.   

Abstract

PURPOSE: Acute porphyrias are metabolic disorders of heme biosynthesis characterized by acute life-threatening attacks. The diagnosis is often missed since clinical presentation is aspecific mimicking other medical and surgical conditions. Variegate porphyria (VP) is an autosomal dominant inherited disease with incomplete penetrance due to decreased activity of the Protoporphyrinogen Oxydase (PPOX) gene; most VP mutations are family specific. We report the case of a 40 year-old woman who presented many times to the emergency department complaining of unexplained abdominal pain and laboratory investigations showed repeatedly hyponatremia. Syndrome of inappropriate antidiuresis (SIAD) was confirmed and measurement of urine porphobilinogen and delta-aminolevulinic acid disclosed the diagnosis of acute porphyria. The genetic analysis of PPOX gene was performed.
METHODS: The entire coding sequence and exon/intron boundaries of PPOX gene were amplified in 5 different Polymerase Chain Reaction (PCR) fragments. In silico prediction of the pathogenicity of the mutation was determined by using different tools, Polyphen2, SNPs&GO, SNPs3D.
RESULTS: The genetic analysis of PPOX gene revealed a novel missense variant c.1376 G > A (p.Cys459Tyr) in heterozygous state. The same variant was later found in one of her cousins with skin lesions and other three younger asymptomatic relatives. We provided evidence that this novel mutation is likely to be pathogenetic.
CONCLUSIONS: Our case highlights the importance of considering VP in the differential diagnosis of SIAD and underlines the role of genetic screening in the management of such patients. The finding of a novel mutation of PPOX gene in our index case has allowed to recognize an affected family.

Entities:  

Keywords:  Acute porphyria; Hyponatremia; Protoporphyrinogen oxidase; SIAD; Valproic acid; Variegate porphyria

Mesh:

Substances:

Year:  2018        PMID: 29516370     DOI: 10.1007/s12020-018-1569-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  14 in total

1.  Structural insight into human variegate porphyria disease.

Authors:  Xiaohong Qin; Ying Tan; Lele Wang; Zhifang Wang; Baifan Wang; Xin Wen; Guangfu Yang; Zhen Xi; Yuequan Shen
Journal:  FASEB J       Date:  2010-11-03       Impact factor: 5.191

2.  Novel heterozygous mutation of protoporphyrinogen oxidase gene in a Chinese patient with variegate porphyria.

Authors:  Shengru Zhou; Xiaoqing Zhao; Hongyan Kang; Renchao Xu; Yunqiu Yu; Jie Zheng; Meng Pan
Journal:  J Dermatol       Date:  2017-07-22       Impact factor: 4.005

3.  [Acute intermittent porphyria and inappropriate ADH syndrome].

Authors:  M T Tébar; L Aguilera
Journal:  Rev Esp Anestesiol Reanim       Date:  2010-05

Review 4.  A challenging diagnosis for potential fatal diseases: recommendations for diagnosing acute porphyrias.

Authors:  Paolo Ventura; Maria Domenica Cappellini; Gianfranco Biolcati; Claudio Carmine Guida; Emilio Rocchi
Journal:  Eur J Intern Med       Date:  2014-05-05       Impact factor: 4.487

Review 5.  The cutaneous porphyrias.

Authors:  Danja Schulenburg-Brand; Ruwani Katugampola; Alexander V Anstey; Michael N Badminton
Journal:  Dermatol Clin       Date:  2014-05-05       Impact factor: 3.478

6.  Novel A219P mutation of hydroxymethylbilane synthase identified in a Chinese woman with acute intermittent porphyria and syndrome of inappropriate antidiuretic hormone.

Authors:  Yingjie Li; Hua Qu; Hang Wang; Huacong Deng; Ziyan Liu
Journal:  Ann Hum Genet       Date:  2015-03-18       Impact factor: 1.670

Review 7.  Update review of the acute porphyrias.

Authors:  Penelope E Stein; Michael N Badminton; David C Rees
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

8.  Contribution of sodium valproate to the syndrome of inappropriate secretion of antidiuretic hormone.

Authors:  T Miyaoka; H Seno; M Itoga; T Kishi; H Ishino; J Horiguchi
Journal:  Int Clin Psychopharmacol       Date:  2001-01       Impact factor: 1.659

9.  HMBS mutations in Chinese patients with acute intermittent porphyria.

Authors:  C-C Yang; H-C Kuo; H-L You; J Wang; C-C Huang; C-Y Liu; M-Y Lan; D A Stephenson; M-J Lee
Journal:  Ann Hum Genet       Date:  2008-09       Impact factor: 1.670

Review 10.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.